Gene transfer for neovascular age-related macular degeneration

Human Gene Therapy

Volumn 22, Issue 5, 2011, Pages 523-529

  Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOSTATIN; DOXYCYCLINE; PIGMENT EPITHELIUM DERIVED FACTOR; RECOMBINANT ENDOSTATIN; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

BINDING AFFINITY; BLOOD VESSEL PERMEABILITY; GENE EXPRESSION; GENE TRANSFER; GENETIC ASSOCIATION; GENETIC TRANSDUCTION; HUMAN; NEOVASCULAR AGE RELATED MACULAR DEGENERATION; NERVE CELL; NONHUMAN; PATHOGENESIS; RETINA CELL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; TREATMENT OUTCOME; VITREOUS BODY;

ANGIOGENESIS INHIBITORS; ANGIOSTATINS; DEPENDOVIRUS; ENDOSTATINS; EYE PROTEINS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; NERVE GROWTH FACTORS; SERPINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; WET MACULAR DEGENERATION;

ANIMALIA;

EID: 79955449947     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2011.050     Document Type: Review

References (54)

1. Apte, S.S., Olsen, B.R., and Murphy, G. (1995). The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270, 14313-14318.
2. Araki, T., Taniwaki, T., Becerra, S.P., et al. (1998). Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apo-ptotic cell death. J. Neurosci. Res. 53, 7-15. (Pubitemid 28308977)
3. Auricchio, A., Behling, K.C., Maguire, A.M., et al. (2002). Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents. Mol. Ther. 6, 490-494. (Pubitemid 35214870)
4. Balaggan, K.S., Binley, K., Esapa, M., et al. (2006). EIAV vector-mediated delivery of endostatin or angiostatin inhibits an-giogenesis and vascular hyperpermeability in experimental CNV. Gene Ther. 13, 1153-1165. (Pubitemid 44084074)
5. Bilak, M.M., Corse, A.M., Bilak, S.R., et al. (1999). Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J. Neu-ropathol. Exp. Neurol. 58, 719-728. (Pubitemid 29328501)
6. Brown, D.M., Kaiser, P.K., Michels, M., et al.; Anchor Study Group (2006). Ranibizumab versus verteporfin for neovas-cular age-related macular degeneration. N. Engl. J. Med. 355, 1432-1444. (Pubitemid 44511558)
7. Campochiaro, P.A., Nguyen, Q.D., Shah, S.M., et al. (2006). Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: Results of a phase I clinical trial. Hum. Gene Ther. 17, 167-176. (Pubitemid 43262032)
8. Cao, W., Tombran-Tink, J., Elias, R., et al. (2001). In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest. Opthalmol. Vis. Sci. 42, 1642-1652.
9. Dawson, D.W., Volpert, O.V., Gillis, P., et al. (1999). Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 285, 245-248. (Pubitemid 29329995)
10. Della, N.G., Campochiaro, P.A., and Zack, D.J. (1996). Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 37, 1921-1924. (Pubitemid 26265045)
11. Edwards, A.O., Ritter, R.R., Abel, K.J., et al. (2005). Complement factor H polymorphism and age-related macular degeneration. Science 308, 421-424. (Pubitemid 40530082)
12. Fukai, N., Eklund, L., Marneros, A.G., et al. (2002). Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21, 1535-1544. (Pubitemid 34614610)
13. Gold, B., Merriam, J.E., Zernant, J., et al. (2006). Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38, 458-462.
14. Haines, J.L., Hauser, M.A., Schmidt, S., et al. (2005). Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419-421. (Pubitemid 40530081)
15. He, Y., Smith, S.K., Day, K.A., et al. (1999). Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol. Endocrinol. 13, 537-545. (Pubitemid 30636421)
16. Honda, M., Sakamoto, T., Ishibashi, T., et al. (2000). Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF.flt-1 receptor gene trans-fection: A role of VEGF and possible treatment for SRN in age-related macular degeneration. Gene Ther. 7, 978-985. (Pubitemid 30386663)
17. Igarashi, T., Miyake, K., Kato, K., et al. (2003). Lentivirus-mediated expression of angiostatin efficiently inhibits neo-vascularization in a murine proliferative retinopathy model. Gene Ther. 10, 219-226. (Pubitemid 36204410)
18. Kachi, S., Binley, K., Yokoi, K., et al. (2009). EIAV vector-mediated co-delivery of endostatin and angiostatin driven by the RPE-specific VMD2 promoter inhibits choroidal neo-vascularization. Hum. Gene Ther. 20, 31-39.
19. Kamei, M., and Hollyfield, J.G. (1999). TIMP-3 in Bruch's membrane: Changes during aging and in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 40, 2367-2375. (Pubitemid 29418393)
20. Kendall, R.L., Wang, G.L., and Thomas, K.A. (1996). Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226, 324-328. (Pubitemid 26331903)
21. Klein, R., Klein, B.E., and Linton, K.L. (1992). Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 99, 933-943.
22. Klein, R.J., Zeiss, C., Chew, E.Y., et al. (2005). Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389. (Pubitemid 40530070)
23. Kwak, N., Okamoto, N., Wood, J.M., and Campochiaro, P.A. (2000). VEGF is an important stimulator in a model of cho-roidal neovascularization. Invest. Ophthalmol. Vis. Sci. 41, 3158-3164.
24. Lai, C.-C., Wu, W.-C., Chen, S.-L., et al. (2001). Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin. Invest. Ophthalmol. Vis. Sci. 42, 2401-2407. (Pubitemid 32848872)
25. Lai, C.M., Shen, W.Y., Brankov, M., et al. (2005). Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol. Ther. 12, 659-668. (Pubitemid 41350147)
26. Lai, Y.K., Shen, W.Y., Brankov, M., et al. (2002). Potential long-term inhibition of ocular neovascularization by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther. 9, 804-813. (Pubitemid 34679308)
27. Li, Q., Miller, R., Han, P.Y., et al. (2008). Intraocular route of administration defines humoral immune response and therapeutic potential. Mol. Ther. 14, 1760-1769.
28. Lukason, M., Dufresne, E., Hillard, R., et al. (2011). Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule. Mol. Ther. 19, 260-265.
29. Maclachlan, T.K., Lukason, M., Collins, M., et al. (2010). Pre-clinical safety evaluation of AAV2-sFLT01: A gene therapy for age-related macular degeneration. Mol. Ther. 19, 326-334.
30. Miki, A., Ueno, S., Wesinger, D.M., et al. (2010). Prolonged blockade of VEGF receptors does not damage retinal photo-receptors or ganglion cells. J. Cell. Physiol. 224, 262-272.
31. Mori, K., Ando, A., Gehlbach, P., et al. (2001a). Inhibition of choroidal neovascularization by intravenous injection of ade-noviral vectors expressing secretable endostatin. Am. J. Pathol. 159, 313-320. (Pubitemid 33704216)
32. Mori, K., Duh, E., Gehlbach, P., et al. (2001b). Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J. Cell. Physiol. 188, 253-263. (Pubitemid 32622916)
33. Mori, K., Gehlbach, P., Ando, A., et al. (2001c). Regression of ocular neovascularization by increased expression of pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci. 43, 2428-2434.
34. Mori, K., Gehlbach, P., Yamamoto, S., et al. (2002). AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43, 1994-2000. (Pubitemid 34587052)
35. Nishijima, K., Ng, Y.S., Zhong, L., et al. (2007). Vascular endo-thelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am. J. Pathol. 171, 53-67. (Pubitemid 47339226)
36. Ohno-Matsui, K., Hirose, A., Yamamoto, S., et al. (2002). In-ducible expression of vascular endothelial growth factor in photoreceptors of adult mice causes severe proliferative retinopathy and retinal detachment. Am. J. Pathol. 160, 711-719. (Pubitemid 34160349)
37. O'Reilly, M.S., Holmgren, S., Shing, Y., et al. (1994). Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328. (Pubitemid 24324921)
38. O'Reilly, M.S., Boehm, T., Shing, Y., et al. (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285. (Pubitemid 28015876)
39. Pechan, P., Rubin, H., Lukason, M., et al. (2009). Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. Gene Ther. 16, 10-16.
40. Raisler, B.J., Berns, K.I., Grant, M.B., et al. (2002). Adeno-associated virus type 2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization. Proc. Natl. Acad. Sci. U.S.A. 99, 8909-8914. (Pubitemid 34693657)
41. Rosenfeld, P.J., Brown, D.M., Heier, J.S., et al.; Marina Study Group (2006). Ranibizumab for neovascular age-related mac-ular degeneration. N. Engl. J. Med. 355, 1419-1431. (Pubitemid 44511557)
42. Rota, R., Riccioni, T., Zaccarini, M., et al. (2004). Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. J. Gene Med. 6, 992-1002. (Pubitemid 40228114)
43. Saint-Geniez, M., Maharaj, A.S.R., Walshe, T.E., et al. (2008). Endogenous VEGF is required for visual function: Evidence for a survival role on Muller cells and photoreceptors. PLoS One 3, e3554.
44. Saint-Geniez, M., Kurihara, T., Sekiyama, E., et al. (2009). An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc. Natl. Acad. Sci. U.S.A. 106, 18751-18756.
45. R1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J. Cell. Physiol. 195, 241-248. (Pubitemid 36384298)
46. Shen, J., Yang, X.R., Xiao, W.H., et al. (2006). Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization. FASEB J. 20, 723-725. (Pubitemid 46671194)
47. Steele, F.R., Chader, G.J., Johnson, L.V., and Tombran-Tink, J. (1993). Pigment epithelium-derived factor: Neurotrophic activity and identification as a member or the serine protease inhibitor gene family. Proc. Natl. Acad. Sci. U.S.A. 90, 1526-1530. (Pubitemid 23058206)
48. Takahashi, K., Luo, T., Saishin, Y., et al. (2002). Sustained transduction of ocular cells with a bovine immunodeficiency viral vector. Hum. Gene Ther. 13, 1305-1316. (Pubitemid 35034510)
49. Takahashi, K., Saishin, Y., Saishin, Y., et al. (2003). Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB J. 17, 896-898.
50. Takahashi, T., Nakamura, T., Hayashi, A., et al. (2000). Inhibition of experimental choroidal neovascularization by over-expression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium. Am. J. Ophthalmol. 130, 774-781. (Pubitemid 32000859)
51. Tobe, T., Ortega, S., Luna, J.D., et al. (1998). Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am. J. Pathol. 153, 1641-1646. (Pubitemid 28509922)
52. Tombran-Tink, J., Chader, G.G., and Johnson, S.V. (1991). PEDF: A pigment epithelium derived factor with potent neuronal differentiating activity. Exp. Eye Res. 53, 411-414.
53. Ueno, S., Pease, M.E., Wersinger, D.M.B., et al. (2008). Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels. J. Cell. Physiol. 217, 13-22.
54. Watanabe, K., Hasegawa, Y., Yamashita, H., et al. (2004). Vaso-hibin as an endothelium-derived negative feedback regulator of angiogenesis. J. Clin. Invest. 114, 898-907. (Pubitemid 39578717)